DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Carisoprodol and Aspirin (Carisoprodol / Aspirin) - Summary

 
 



SUMMARY

CARISOPRODOL AND ASPIRIN TABLETS, USP                     7869-02

This is a combination product containing Carisoprodol, a centrally-acting muscle relaxant, plus aspirin, an analgesic with antipyretic and anti-inflammatory properties. It is available as a two layered, white and light lavender round tablet for oral administration.

Carisoprodol and Aspirin Tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of pain, muscle spasm, and limited mobility associated with acute, painful musculoskeletal conditions.


See all Carisoprodol and Aspirin indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Carisoprodol and Aspirin (Carisoprodol / Aspirin)

Anal sex between young men and women often seems coercive and painful
Source: Sexual Health / STDs News From Medical News Today [2014.08.15]
Anal sex between young men and women often seems coercive and painful, suggests research published in the online journal BMJ Open.

Painkillers May Halve Risk of Breast Cancer Return in Obese Women: Study
Source: MedicineNet Chronic Pain Specialty [2014.08.15]
Title: Painkillers May Halve Risk of Breast Cancer Return in Obese Women: Study
Category: Health News
Created: 8/14/2014 12:35:00 PM
Last Editorial Review: 8/15/2014 12:00:00 AM

Neurostimulation for Pain: Earlier May Be Better
Source: Medscape NeurologyHeadlines [2014.08.14]
Stimulation of the spinal cord, peripheral nerves or areas of the brain is clinically effective and cost-effective and in many cases should be done earlier in the treatment course.
Medscape Medical News

For pediatric knee surgery, regional anesthesia reduces pain, speeds recovery
Source: Bones / Orthopedics News From Medical News Today [2014.08.14]
A recent study of an ultrasound-guided regional anesthesia technique, called femoral nerve block, shows that it leads to less opioid use and allows the majority of patients to go home within hours of...

Seeking biomarkers to improving treatment of painful bladder condition
Source: Urology / Nephrology News From Medical News Today [2014.08.14]
Taking advantage of technology that can analyze tissue samples and measure the activity of thousands of genes at once, scientists at Wake Forest Baptist Medical Center are on a mission to better...

more news >>

Clinical Trials Related to Carisoprodol and Aspirin (Carisoprodol / Aspirin)

Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back [Recruiting]
The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.

Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis [Completed]
The purpose of this study is to determine whether this topical NF-kappaB Decoy candidate is safe in persons with atopic dermatitis. Preliminary evidence of efficacy (whether it is working) will also be evaluated.

A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back [Recruiting]
The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.

A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol [Not yet recruiting]
Non inferiority, multicentric, double blind study whose the primary objective is to compare the effectiveness of two products in pain reduction. Primary endpoint: reduction in pain average at day 7 compared to day 1(baseline), using Analogue Visual Scale (AVS) for pain evaluation. Secondary endpoint: to evaluate the products safety at the gastrointestinal system.

Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS) [Recruiting]
The purpose of this study is to determine the relationship between lipid-induced inflammation and ovarian androgen secretion in women with polycystic ovary syndrome (PCOS); and to examine the effect of salsalate and polygonum cuspidatum extract (PCE) containing resveratrol on lipid-induced inflammation, ovarian androgen secretion, body composition and ovulation in a subset of normal weight women with PCOS.

more trials >>


Page last updated: 2014-08-15

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014